In in vitro studies with human AML cell line (MV4;11) it was observed that dBET1 causes a marked reduction in BRD4 levels (>85%) at concentrations in the nanomolar range (DC50 = 430 nM).124. Here, BRD4 is linked to acute myeloid leukemia.